Xu Wenyan, Guo Zhenxing
Department of Hematology/Oncology, First Hospital of Tsinghua University, Beijing, China.
SAGE Open Med Case Rep. 2022 Mar 22;10:2050313X221088146. doi: 10.1177/2050313X221088146. eCollection 2022.
Hemophagocytic lymphohistiocytosis is a rare and almost universally fatal disease in adults. A 60-year-old female patient presented to our hospital with a 3-day history of weakness and anorexia. Physical examination revealed severe pallor without lymphadenopathy or hepatosplenomegaly. The initial blood test showed a hemoglobin level of 2.6 g/dL and a platelet count of 76 × 10/L. Later the patient experienced persistent high fever for 1 week without any obvious infective symptoms. Biochemical examination revealed hyperferritinemia and low natural killer cell viability. The bone marrow morphology showed hemophagocytosis and infiltration with metastatic small-cell lung cancer. The patient was diagnosed as small-cell lung cancer-related hemophagocytic lymphohistiocytosis. Subsequently, she underwent chemotherapy with dexamethasone and etoposide. However, the patient succumbed within 2 weeks of presentation due to rapidly progressive disease. In conclusion, we reported the first hemophagocytic lymphohistiocytosis case with small-cell lung cancer. It is critical to have early identification of hemophagocytic lymphohistiocytosis in patients with small-cell lung cancer.
噬血细胞性淋巴组织细胞增生症在成人中是一种罕见且几乎普遍致命的疾病。一名60岁女性患者因3天的乏力和厌食病史前来我院就诊。体格检查发现严重苍白,无淋巴结肿大或肝脾肿大。初始血液检查显示血红蛋白水平为2.6 g/dL,血小板计数为76×10/L。后来患者持续高热1周,无任何明显感染症状。生化检查显示铁蛋白血症和自然杀伤细胞活力低下。骨髓形态显示噬血细胞现象以及转移性小细胞肺癌浸润。该患者被诊断为小细胞肺癌相关的噬血细胞性淋巴组织细胞增生症。随后,她接受了地塞米松和依托泊苷化疗。然而,患者在就诊后2周内由于疾病迅速进展而死亡。总之,我们报告了首例小细胞肺癌合并噬血细胞性淋巴组织细胞增生症病例。早期识别小细胞肺癌患者中的噬血细胞性淋巴组织细胞增生症至关重要。